Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorte Glintborg

Showing results (61-70 of 173) with videos related to

Pageof 18
Sort By:
The Journal of Clinical Endocrinology and Metabolism|April 19, 2014
Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndromeDorte Glintborg, Magda Lambaa Altinok, Hanne Mumm, et al.
Diabetes Care|November 15, 2007
Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatmentDorte Glintborg, Kurt Højlund, Marianne Andersen, et al.
Human Reproduction (Oxford, England)|March 25, 2016
Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndromeHanne Mumm, Magda Lambaa Altinok, Jan Erik Henriksen, et al.
Endocrine Connections|February 24, 2018
Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOSDorte Glintborg, Magda Lambaa Altinok, Pernille Ravn, et al.
Ugeskrift for Laeger|January 22, 2010
[Endocrinological assessment, treatment and follow-up on polycystic ovary syndrome]Dorte Glintborg, Jørgen Rungby, Peter Eskildsen, et al.
Basic & Clinical Pharmacology & Toxicology|August 24, 2017
The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized TrialAndreas J T Pedersen, Tore Bjerregaard Stage, Dorte Glintborg, et al.
European Journal of Endocrinology|March 14, 2025
Autoimmune diseases in 3812 Danish transgender persons and 38 120 cisgender controls before and after transgender care: a register-based cohort studyDorte Glintborg, Jens-Jakob Kjer Møller, Katrine Hass Rubin, et al.
Clinical Endocrinology|August 14, 2025
Incidence of Autoimmune Diseases in 30,340 Danish Women With Polycystic Ovary Syndrome (PCOS) Compared to 151,520 Controls. A National Cohort StudyDorte Glintborg, Jens-Jakob Kjer Møller, Katrine Hass Rubin, et al.
European Journal of Clinical Pharmacology|July 20, 2012
The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspectiveAnton Pottegård, Bine Kjøller Bjerregaard, Dorte Glintborg, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2022
Approach to the Patient With Glucocorticoid-induced Adrenal InsufficiencyStina Willemoes Borresen, Marianne Klose, Dorte Glintborg, et al.
Pageof 18

Showing results (61-70 of 173) with videos related to

Sort By:
Pageof 18
The Journal of Clinical Endocrinology and Metabolism|April 19, 2014
Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndromeDorte Glintborg, Magda Lambaa Altinok, Hanne Mumm, et al.
Diabetes Care|November 15, 2007
Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatmentDorte Glintborg, Kurt Højlund, Marianne Andersen, et al.
Human Reproduction (Oxford, England)|March 25, 2016
Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndromeHanne Mumm, Magda Lambaa Altinok, Jan Erik Henriksen, et al.
Endocrine Connections|February 24, 2018
Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOSDorte Glintborg, Magda Lambaa Altinok, Pernille Ravn, et al.
Ugeskrift for Laeger|January 22, 2010
[Endocrinological assessment, treatment and follow-up on polycystic ovary syndrome]Dorte Glintborg, Jørgen Rungby, Peter Eskildsen, et al.
Basic & Clinical Pharmacology & Toxicology|August 24, 2017
The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized TrialAndreas J T Pedersen, Tore Bjerregaard Stage, Dorte Glintborg, et al.
European Journal of Endocrinology|March 14, 2025
Autoimmune diseases in 3812 Danish transgender persons and 38 120 cisgender controls before and after transgender care: a register-based cohort studyDorte Glintborg, Jens-Jakob Kjer Møller, Katrine Hass Rubin, et al.
Clinical Endocrinology|August 14, 2025
Incidence of Autoimmune Diseases in 30,340 Danish Women With Polycystic Ovary Syndrome (PCOS) Compared to 151,520 Controls. A National Cohort StudyDorte Glintborg, Jens-Jakob Kjer Møller, Katrine Hass Rubin, et al.
European Journal of Clinical Pharmacology|July 20, 2012
The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspectiveAnton Pottegård, Bine Kjøller Bjerregaard, Dorte Glintborg, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2022
Approach to the Patient With Glucocorticoid-induced Adrenal InsufficiencyStina Willemoes Borresen, Marianne Klose, Dorte Glintborg, et al.
Pageof 18